PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Purified anti-β-Dystroglycan, 25 µg
Purified anti-β-Tubulin, 250 μl
Purified Non-muscle Myosin Heavy Chain II-A, 100 μl
Purified Non-muscle Myosin Heavy Chain II-B, 100 μl
Recombinant Human APP751, 25 µg
Recombinant Human APP770, 25 µg
Recombinant Human Tau-352 (0N3R), 25 µg
Recombinant Human Tau-381 (1N3R), 25 µg
Recombinant Human Tau-383 (0N4R), 25 µg
Recombinant Human Tau-410 (2N3R), 25 µg
Recombinant Human Tau-412 (1N4R), 25 µg
Recombinant Human Tau-441 (2N4R), 25 µg
RetroNectin reagent
Ultra-LEAF™ Purified anti-CD325 (N-Cadherin), 100 µg
Ultra-LEAF™ Purified anti-Glutamic Acid Decarboxylase (GAD65/GAD2), 100 µg
Ultra-LEAF™ Purified anti-Histone Lysine Demethylase (NO66), 100 µg